Non-Antibody Products
Page 1 of 45,310
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| 88255-01-0 | Purity ≥98%. MW: 420.46 | 100 mg, 500 mg | MBS132338 | MYBIOSOURCE INC. | More Info |
| 95343-20-7 | Purity ≥98%. MW: 664.1 | 100 mg, 500 mg | MBS130215 | MYBIOSOURCE INC. | More Info |
| 92.1 | Tissue: uvea; Tumor: melanoma, melanin production. | 1 vial | ABC-TC444S | ACCEGEN BIOTECH | More Info |
| 380 | Tissue: peripheral blood; Tumor: leukemia, pre-B cell; Derived from a pati… | 1 vial | ABC-TC442S | ACCEGEN BIOTECH | More Info |
| 1301 | Human T-cell leukaemia. 1301 Is a sub-line of CCRF-CEM. It has unusually l… | 1 vial | ABC-TC0001 | ACCEGEN BIOTECH | More Info |
| 5637 | 5637 Cell line was established from the primary bladder carcinoma of a 68-… | 1 vial | ABC-TC0015 | ACCEGEN BIOTECH | More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 10 mg | 30780-10 | CAYMAN CHEMICAL COMPANY | More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 25 mg | 30780-25 | CAYMAN CHEMICAL COMPANY | More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 5 mg | 30780-5 | CAYMAN CHEMICAL COMPANY | More Info |
| 666-15 | An inhibitor of CREB-mediated gene transcription (IC50 = 81 nM in a cell-b… | 50 mg | 30780-50 | CAYMAN CHEMICAL COMPANY | More Info |
| 13323-67-6 | Purity ≥98%. MW: 286.3 | 5 mg | orb1290280 | BIORBYT LTD. | More Info |
| 1360900-71-5 | MW: 228.0427 | 100 mg | orb1146568 | BIORBYT LTD. | More Info |
| 14787-34-9 | Purity ≥98%. MW: 358.4 | 5 mg | orb1290300 | BIORBYT LTD. | More Info |
| 1776-30-3 | Purity ≥98%. MW: 240.3 | 20 mg | orb1290287 | BIORBYT LTD. | More Info |
| 20127-63-3 | Purity ≥98%. MW: 196.2 | 20 mg | orb1290297 | BIORBYT LTD. | More Info |
| 408324-00-5 | Purity ≥98%. MW: 332.4 | 5 mg | orb1290294 | BIORBYT LTD. | More Info |
| 42206-91-7 | Purity ≥98%. MW: 372.4 | 10 mg | orb1290298 | BIORBYT LTD. | More Info |
| 53596-71-7 | Purity ≥98%. MW: 242.3 | 20 mg | orb1290277 | BIORBYT LTD. | More Info |
| 653-47 | Purity 98.00%. MW: 370.83 | 50 mg, 100 mg | orb1685345 | BIORBYT LTD. | More Info |
| 666-15 | 666-15 is a potent and selective CREB inhibitor with an IC50 of 81 nM. MW:… | 1 g, 100 mg, 250 mg, 10 mM * 1 mL in DMSO | orb401883 | BIORBYT LTD. | More Info |
| 666-15 | Purity 99.77%. MW: 620.52 | 200 mg, 100 mg, 1 mg, 50 mg, 25 mg, 10 mg, 5 mg | orb1301894 | BIORBYT LTD. | More Info |
| 666-15 | n/a | 5 mg, 10 mg, 50 mg | orb1889352 | BIORBYT LTD. | More Info |
| 8011-6561 | Purity 98.00%. MW: 291.39 | 5 mg, 50 mg, 100 mg | orb1709067 | BIORBYT LTD. | More Info |
| 8- | MW: 232.191 | 5 mg | orb421163 | BIORBYT LTD. | More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 10 mg | 40747-10 | CAYMAN CHEMICAL COMPANY | More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 25 mg | 40747-25 | CAYMAN CHEMICAL COMPANY | More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 5 mg | 40747-5 | CAYMAN CHEMICAL COMPANY | More Info |
| 11-10-8 | An ionizable cationic lipid; has been used in the generation of LNPs for m… | 50 mg | 40747-50 | CAYMAN CHEMICAL COMPANY | More Info |
| 119-23 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 1 mg | 41386-1 | CAYMAN CHEMICAL COMPANY | More Info |
| 119-23 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 10 mg | 41386-10 | CAYMAN CHEMICAL COMPANY | More Info |
| 119-23 | An ionizable cationic lipid; has been used in the generation of LNPs for t… | 5 mg | 41386-5 | CAYMAN CHEMICAL COMPANY | More Info |
| 293 | n/a | n/a | 103 | NIH HIV REAGENT PROGRAM | More Info |
| A 205804 | Purity ≥98%. MW: 300.39 | 100 mg, 500 mg | MBS132392 | MYBIOSOURCE INC. | More Info |
| A 66 | Purity ≥98%. MW: 393.52 | 100 mg, 500 mg | MBS132169 | MYBIOSOURCE INC. | More Info |
| A 740003 | Purity ≥98%. MW: 474.565 | 100 mg, 500 mg | MBS132187 | MYBIOSOURCE INC. | More Info |
| A 740003 | Purity >98%. A 740003 is a novel competitive antagonist of P2X7 receptors… | 10 mg, 25 mg, 50 mg | MBS384091 | MYBIOSOURCE INC. | More Info |
| A 769662 | Purity ≥98%. MW: 360.39 | 100 mg, 500 mg | MBS130892 | MYBIOSOURCE INC. | More Info |
| A 769662 | Purity 97%+. MW: 360.39 | 5 mg, 1ml/10mM (in DMSO), 10 mg | MBS576261 | MYBIOSOURCE INC. | More Info |
| A 803467 | Purity >98%. A 803467 is a selective blocker of NaV1.8 channels (IC50 valu… | 10 mg, 1 mL (in DMSO), 25 mg | MBS384093 | MYBIOSOURCE INC. | More Info |
| A 83-01 | Purity ≥98% by HPLC. Background: A selective inhibitor of TGF-beta type… | 1 mg | MBS842636 | MYBIOSOURCE INC. | More Info |
| A 83-01 | Purity ≥98%. MW: 421.52 | 100 mg, 500 mg | MBS132328 | MYBIOSOURCE INC. | More Info |
| A 83-01 | Purity >98%. A83-01 is a TGF-β kinase / activin receptor like kinase… | 5 mg, 10 mg, 25 mg | MBS384095 | MYBIOSOURCE INC. | More Info |
| A 922500 | MW: 428.48 | 5 mg | MBS8506458 | MYBIOSOURCE INC. | More Info |
| A 922500 | Purity ≥98%. MW: 428.488 | 100 mg, 500 mg | MBS130245 | MYBIOSOURCE INC. | More Info |
| A 967079 | Purity >98%. A 967079 is a selective TRPA1 channel blocker (IC50 values ar… | 10 mg, 25 mg, 50 mg | MBS384097 | MYBIOSOURCE INC. | More Info |
| A-1155463 | Purity >98%. A-1155463 is a highly potent and selective BCL-XL inhibitor,… | 5 mg, 10 mg, 50 mg | MBS384082 | MYBIOSOURCE INC. | More Info |
| A-1210477 | Purity ≥98%. MW: 886.51 | 100 mg, 500 mg | MBS131280 | MYBIOSOURCE INC. | More Info |
| A-1210477 | Purity ≥99%. MW: 850.04 | 2 mg, 5 mg, 10 mg | MBS575263 | MYBIOSOURCE INC. | More Info |
| A-1210477 | Purity >98%. A-1210477 is a potent and selective MCL-1 inhibitor. A-121047… | 5 mg, 10 mg, 25 mg | MBS384084 | MYBIOSOURCE INC. | More Info |
| A-1331852 | Purity ≥98%. MW: 658.82 | 100 mg, 500 mg | MBS131656 | MYBIOSOURCE INC. | More Info |
Services
Our Mission
We provide personalized and compassionate care to our patients, working closely with healthcare providers to ensure the best possible outcomes. Our services are always free of charge.
Our Values
We founded our company to make a positive impact on the world through biotechnology. We believe that science can change the world for the better.
Our team
Our diverse team of 25 scientists and researchers, ranging in age from 25 to 66, is passionate about making a difference in the world. We are always looking for talented individuals to join our team.
" The innovative solutions from Company Linscott’s\ Directory\ of\ Immunological\ and\ Biological\ Reagents have transformed our research capabilities. Their biotechnology products are truly game-changers." - Dr. Emily Carter, Lead Researcher at BioInnovate Labs "
" The innovative solutions from Company Linscott’s\ Directory\ of\ Immunological\ and\ Biological\ Reagents have transformed our research capabilities. Their biotechnology products are truly game-changers." - Dr. Emily Carter, Lead Researcher at BioInnovate Labs "
" The innovative solutions from Company Linscott’s\ Directory\ of\ Immunological\ and\ Biological\ Reagents have transformed our research capabilities. Their biotechnology products are truly game-changers." - Dr. Emily Carter, Lead Researcher at BioInnovate Labs "
Collaborators and testimonials
Use this section to highlight our scientific achievements and partnerships.
